Sobi News and Activities

Presence

Sobi is a pharmaceutical company that develops and sells treatments for rare diseases and specialty conditions. Its medicines and support services serve patients, hospitals, and healthcare professionals.

Sobi products and services overview:

Rare disease drugs
Hematology treatments
Immunology therapies
Specialty care medicines
Patient support services

Revenue: ~$2 billion

Employees: 1,800

Headquarters: Stockholm, Sweden

Sobi is owned by Investor AB.

Investor AB is one of the...

Investor AB is a company listed under the stock ticker INVEb.ST (SE).

Investor AB has a direct presence in 7 countries.

Investor AB has 15 subsidiaries including Advanced Instruments, Kunskapsskolan and Molnlycke Health Care.

They are in:

Acquisition, funding and merger involving Investor AB.

Sobi has announced the acquisition of Arthrosi Therapeutics (posted on February 12 2026).
Sobi has announced the acquisition of Arthrosi Therapeutics (posted on December 15 2025).

Executives

View the org chart displaying its 68 main executives

Most searched biographies at Sobi

Popular executive movements at Sobi

Helena Saxon, Director, has left the company (posted on October 23 2025).

Popular executive movements at Investor AB

Isabelle Kocher, Director, will leave the company on May 7, 2026 (posted on March 27 2026).
Tom Johnstone, Director, will leave the company on May 7, 2026 (posted on March 27 2026).
Ulrika Elfving will join the company as General Counsel in Apr. 2026 (posted on December 12 2025).

Create your alert
to follow the executive moves at Sobi.